Titre:
  • Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration
Auteur:Bossuyt, Veerle Ilse Julie; Piccart-Gebhart, Martine; Salgado, Roberto
Informations sur la publication:Annals of oncology, 26, 7, page (1280-1291)
Statut de publication:Publié, 2015-07
Sujet CREF:Hématologie
Cancérologie
Mots-clés:Breast cancer
Neoadjuvant systemic therapy
Pathologic assessment
Pathologic complete response
Residual disease
Response evaluation
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdv161
info:scp/84940719491